In December 2022, we obtained a Canadian cultivation license for producing high-quality medical cannabis. At the same time, we registered our genetic strains with Health Canada. In January 2023, the company obtained a license from the Canadian Revenue Agency (CRA).
Our forecast is to qualify for the Israeli license (IMC GMP) by August 2023. Once qualified, we plan to start exporting to Israel by September 2023.
We expect to qualify for the EU license (GMP) by December 2023.
